title: [The surgery after. . . retroperitoneal lymph node dissection and surgery of the residual masses after chemotherapy for advanced testicular cancer].
abstract: Thirty-six cases of retroperitoneal lymph node dissections for residual mass after chemotherapy for testicular cancer are reported. In a reference center, the recruitment is modified by the severity of the situations related to very big masses, tumors of poor prognosis and resistant tumors. Lymph node dissection is often atypical and surgery of metastatic residual masses is frequent (13 operations). The 8-year global survival remains stable, over 90%. The 5-year cumulated risk of recurrence is 20%, but these situations can be overtaken.
authors.affiliation: Département de chirurgie, Centre Alexis-Vautrin, Vandoeuvre-lès-Nancy, France. f.guillemin@nancy.fnclcc.fr
authors.forename: François
authors.initials: F
authors.lastname: Guillemin
authors.forename: Jean-François Betala
authors.initials: JF
authors.lastname: Belinga
authors.forename: Frédéric
authors.initials: F
authors.lastname: Marchal
authors.forename: Philippe
authors.initials: P
authors.lastname: Rauch
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Verhaeghe
mesh_terms: D000293:Adolescent; D000328:Adult; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D018365:Neoplasm, Residual; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D012187:Retroperitoneal Space; D018239:Seminoma / Q000188:drug therapy / Q000473:pathology / Q000556:secondary / Q000601:surgery; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D047368:Tumor Burden; D055815:Young Adult